- Published
Antibody responses to a suite of novel serological markers for malaria surveillance demonstrate strong correlation with clinical and parasitological infection across seasons and transmission settings in The Gambia
Wu, L., Mwesigwa, J., Affara, M., Bah, M., Correa, S., Hall, T., Singh, S. K., Beeson, J. G., Tetteh, K. K. A., Kleinschmidt, I., D'Alessandro, U. & Drakeley, C., 2020, In: BMC Medicine. 18, 1, 304.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Antibody levels against GLURP R2, MSP1 block 2 hybrid and AS202.11 and the risk of malaria in children living in hyperendemic (Burkina Faso) and hypo-endemic (Ghana) areas
Adu, B., Cherif, M. K., Bosomprah, S., Diarra, A., Arthur, F. K. N., Dickson, E. K., Corradin, G., Cavanagh, D. R., Theisen, Michael, Sirima, S. B., Nebie, I. & Dodoo, D., 27 Feb 2016, In: Malaria Journal. 15, 1, 123.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Antibodies to malaria vaccine candidates are associated with chloroquine or sulphadoxine/pyrimethamine treatment efficacy in children in an endemic area of Burkina Faso
Diarra, A., Nebie, I., Tiono, A., Soulama, I., Ouedraogo, A., Konate, A., Theisen, Michael, Dodoo, D., Traore, A. & Sirima, S. B., 2012, In: Malaria Journal. 11, 1, p. 79Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Antibodies against the Plasmodium falciparum glutamate-rich protein from naturally exposed individuals living in a Brazilian malaria-endemic area can inhibit in vitro parasite growth
Pratt-Riccio, L. R., Bianco, C., Totino, P. R. R., Perce-Da-Silva, D. D. S., Silva, L. A., Riccio, E. K. P., Ennes-Vidal, V., Neves-Ferreira, A. G. C., Perales, J., Da Rocha, S. L. G., Dias-Da-Silva, F., Ferreira-da-Cruz, M. D. F., Daniel-Ribeiro, C. T., De Oliveira-Ferreira, J., Theisen, Michael, Carvalho, L. J. D. M. & Banic, D. M., 2011, In: Memórias do Instituto Oswaldo Cruz. 106 Suppl 1, p. 34-43 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Anti-gametocyte antigen humoral immunity and gametocytemia during treatment of uncomplicated falciparum malaria: A multi-national study
O'Flaherty, K., Chan, J-A., Cutts, J. C., Zaloumis, S. G., Ashley, E. A., Phyo, A. P., Drew, D. R., Dondorp, A. M., Day, N. P., Dhorda, M., Fairhurst, R. M., Lim, P., Amaratunga, C., Pukrittayakamee, S., Hien, T. T., Htut, Y., Mayxay, M., Faiz, M. A., Mokuolu, O. A., Onyamboko, M. A. & 9 others, , 2022, In: Frontiers in Cellular and Infection Microbiology. 12, p. 804470Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Analysis of the OspE determinants involved in binding of factor H and OspE-targeting antibodies elicited during Borrelia burgdorferi infection in mice
Metts, M. S., McDowell, J. V., Theisen, Michael, Hansen, Paul Robert & Marconi, R. T., 1 Jun 2003, In: Infection and Immunity. 71, 6, p. 3587-3596 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Acquisition of natural humoral immunity to P. falciparum in early life in Benin: impact of clinical, environmental and host factors
Dechavanne, C., Sadissou, I., Bouraima, A., Ahouangninou, C., Amoussa, R., Milet, J., Moutairou, K., Massougbodji, A., Theisen, Michael, Remarque, E. J., Courtin, D., Nuel, G., Migot-Nabias, F. & Garcia, A., 2016, In: Scientific Reports. 6, 9 p., 33961.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
ANTIBODY DEPENDENT CELLULAR INHIBITION IS ASSOCIATED WITH PROTECTION AGAINST FEBRILE MALARIA IN A LONGITUDINAL COHORT STUDY INVOLVING GHANAIAN CHILDREN
Tiendrebeogo, R. W., Nov 2017, In: American Journal of Tropical Medicine and Hygiene. 95, 5, p. 112-112Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
- Published
A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria
Murungi, L. M., Kamuyu, G., Lowe, B., Bejon, P., Theisen, Michael, Kinyanjui, S. M., Marsh, K. & Osier, F. H. A., 20 Aug 2013, In: Vaccine. 31, 37, p. 3936-42 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
A synthetic TLR4 agonist formulated in an emulsion enhances humoral and Type 1 cellular immune responses against GMZ2 - A GLURP-MSP3 fusion protein malaria vaccine candidate
Lousada-Dietrich, S., Jogdand, P. S., Jepsen, S., Valadão Vaz dos Santos Pinto, V. M., Ditlev, S. B., Christiansen, M., Larsen, S. O., Fox, C. B., Raman, V. S., Howard, R. F., Vedvick, T. S., Ireton, G., Carter, D., Reed, S. G. & Theisen, Michael, 12 Apr 2011, In: Vaccine. 29, 17, p. 3284-92 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
Most downloads
-
310
downloads
Natural antibody responses to Plasmodium falciparum MSP3 and GLURP(R0) antigens are associated with low parasite densities in malaria patients living in the Central Region of Ghana
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
230
downloads
Construct design, production, and characterization of Plasmodium falciparum 48/45 R0.6C subunit protein produced in Lactococcus lactis as candidate vaccine
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
210
downloads
Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity
Research output: Contribution to journal › Journal article › Research › peer-review
Published
Latest publications
Clinical formulation development of Plasmodium falciparum malaria vaccine candidates based on Pfs48/45, Pfs230, and PfCSP
Research output: Contribution to journal › Journal article › Research › peer-review
A randomized first-in-human phase I trial of differentially adjuvanted Pfs48/45 malaria vaccines in Burkinabé adults
Research output: Contribution to journal › Journal article › Research › peer-review
A Pfs48/45-based vaccine to block Plasmodium falciparum transmission: phase 1, open-label, clinical trial
Research output: Contribution to journal › Journal article › Research › peer-review